Hello, I am Dr. Hidenori Shimada of Grand Green Osaka Umekita Clinic in Osaka, Japan.
If you live outside Japan and are considering NK cell therapy, the idea of travelling to Osaka can raise as many questions as the treatment itself. How many visits will there be? Who explains the details in English? What should you bring from your home doctor? This article walks through the practical points international patients commonly want to settle before booking, so that your first consultation can be focused and productive.
In short, NK cell therapy is a medical decision that needs a doctor’s assessment, and good preparation helps you and the clinic make that decision together. Nothing here is a promise of results, and it is not a substitute for the advice of your own oncology team.
Start by understanding what the therapy is and is not
NK (natural killer) cells are innate immune cells that circulate in the blood and are known to recognize and attack cancer cells and virus-infected cells. In NK cell therapy offered at Grand Green Osaka Umekita Clinic, NK cells are collected from a standard blood draw, activated and expanded at a specialized cell processing facility, and then returned to your body by intravenous infusion. The aim is to reinforce immune function by returning more cells with higher activity.
It is important to hold realistic expectations. NK cell therapy is an option to consider alongside, not instead of, standard cancer treatment such as surgery, chemotherapy, or radiation therapy. Responses differ from person to person, and the therapy has limits. Before planning any travel, it helps to be clear about your own goal, for example supporting immune function during treatment, or considering the period after standard treatment has ended.
Gather your medical information before you travel
A doctor in Osaka can only give meaningful advice if the picture of your health is complete. Because the therapy is provided as a self-pay (non-insured) treatment, your first consultation is the point at which a physician reviews whether it is appropriate for you. Preparing records in advance can make that conversation more efficient and may reduce the need for repeat explanations.
- A summary letter from your current oncologist, including diagnosis, stage, and treatment history.
- Recent blood test results and imaging reports, ideally with an English translation or English-language originals.
- A list of your current medicines and supplements, and any known allergies.
- Dates of planned or ongoing surgery, chemotherapy, or radiation, so timing can be discussed.
- Your own written list of questions and priorities.
If you are not sure which documents are useful, you can ask the clinic what to send beforehand. It is also reasonable to tell your home oncologist that you are exploring this option, since the therapy is generally described as compatible with standard treatment and the clinic can coordinate with the institution providing it, with your consent.
Understand how Japanese regulation shapes the treatment
In Japan, cell therapies of this kind are provided under the Act on the Safety of Regenerative Medicine. Under this framework, a clinic submits a treatment provision plan that is reviewed and accepted, and the cells are processed at a licensed facility. This is a framework for oversight and patient protection; it does not mean that the outcome of any individual treatment can be predicted.
For international patients, this also means the treatment is a self-pay medical service. It is not covered by Japan’s public health insurance, and overseas travel insurance may not cover it either. Ask the clinic to explain the fees, the number of infusions that may be recommended, the expected duration of the course, and the possible risks and side effects. Temporary fever or fatigue may occur, and a doctor should explain what to watch for and when to get in touch.
Think through the schedule, the number of visits, and your stay
Because NK cells are collected from the blood, cultured outside the body, and then returned by infusion, the treatment is not completed in a single visit. There is a gap between blood collection and infusion, and a course often involves more than one infusion. The right schedule depends on your condition and your doctor’s judgment, so avoid booking non-refundable flights or hotels until the plan is confirmed after your consultation.
Useful questions to ask include how long the processing period is, whether any steps can be coordinated remotely, how follow-up will work after you return home, and what to do if you feel unwell after returning. Treatment is delivered by a blood draw and an IV drip without hospitalization, so many patients can continue ordinary daily activities, but you should confirm what is appropriate for you, including travel on the same day as an infusion.
Check language support and how decisions are made
Informed consent is the heart of any medical decision, and it works best when you can follow every detail in a language you understand. The clinic offers an information page and a contact route for international patients, and you can ask how interpretation and English-language explanations are handled during the consultation and the consent process. If you are travelling with family, ask whether they can join the discussion.
Do not feel pressured to decide on the day. A careful clinic will welcome time for you to consider the information, to speak with your home doctor, and to compare options. If something is unclear about the benefits, limits, or costs, say so and ask for it in writing.
Take the next step with a consultation
Planning a trip for NK cell therapy involves medical, regulatory, and practical questions, and each deserves a clear answer before you commit. Collect your records, write down your questions, and ask the clinic in Osaka (Umeda) about eligibility, fees, schedule, risks, and follow-up. You can find more detail on the NK cell therapy page and the information page for international patients at Grand Green Osaka Umekita Clinic.
Final decisions about whether NK cell therapy is suitable, and how it fits with your standard cancer treatment, are made together with a physician after an in-person or online consultation.
- 1Clarify your goal
- 2Gather recordsOncologist letter, tests
- 3Know the rules
- 4Ask about feesSelf-pay treatment
- 5Plan the schedule
This figure is a conceptual summary of the article content
References
- PubMed: Natural killer cell therapies. (2024)
- PubMed: NK cells and ILCs in tumor immunotherapy. (2021)
- PubMed: CAR-NK cell therapy: promise and challenges in solid tumors. (2025)
- PubMed: The effect of low-dose IL-2 and Treg adoptive cell therapy in patients with type 1 diabetes. (2021)
- PubMed: CD56bright cytokine-induced memory-like NK cells and NK-cell engagers synergize against non-small cell lung cancer cancer-stem cells. (2025)
- PMC: Natural killer cell-enriched donor lymphocyte infusions from A 3-6/6 HLA matched family member following nonmyeloablative allogeneic stem cell transplantation. (2010)
- PMC: Autologous NK cells as consolidation therapy following stem cell transplantation in multiple myeloma. (2022)
- PMC: Autologous stem cell transplant recipients tolerate haploidentical related-donor natural killer cell-enriched infusions. (2013)
- MHLW (Japan): Regenerative Medicine — Ministry of Health, Labour and Welfare, Japan
Supervising Physician
Director, Medical Corporation Shimada Clinic
Head of Clinical Practice, Grand Green Osaka Umekita Clinic
Hidenori Shimada
Graduated from the University of Tokushima Faculty of Medicine in 2005. After his initial residency, he obtained U.S. medical certification (ECFMG) and trained as a sub-intern in general surgery at the University of Washington. After completing the doctoral program at Kyoto University Graduate School of Medicine and working as a researcher at the Center for iPS Cell Research and Application (CiRA), Kyoto University, he founded Shimada Clinic in 2013. At Grand Green Osaka Umekita Clinic (https://umekitaclinic.org), he is engaged in a wide range of care, from internal medicine and pediatrics to cell therapy and aesthetic medicine.
* The physician supervision of this article covers its academic content only and does not constitute a recommendation of any specific treatment or product.